Molecular and genetic characteristics strongly influence breast cancer prognosis and treatment, with HER2 amplification (human epidermal growth factor receptor 2 [ERBB2]) and hormone receptor (HR; estrogen receptor [ER] and progesterone receptor [PR]) expression being the best examples. Here, ESR1 is linked to breast cancer.